Suven Pharma stock rises 4% on acquisition by Advent International
Advent plans to merge its portfolio company Cohance Lifesciences with Suven to build an end-to-end CDMO and merchant API.
Advent plans to merge its portfolio company Cohance Lifesciences with Suven to build an end-to-end CDMO and merchant API.
Thanks to recent surge in share prices, YES Bank jumped to 92nd position in overall m-cap ranking on the BSE.
YES Bank will sell up to 10% stake each to global private equity investors Carlyle Group and Advent International to raise equity capital of ₹8,900 crore.